EMDR vs MDMA-Assisted Therapy
A side-by-side comparison of recorded mechanisms, evidence review status, related condition topics, and philosophical roots.
At a glance
Source checks, condition-specific assessments and expert review are separate steps. Each assessment applies only to its stated population and use. Topic links do not establish comparative effectiveness.
EMDR
- Tradition
- Trauma-Focused
- Founder
- Francine Shapiro (1989)
- Review status
- 2 condition assessments available
- Official sources
Guidelines and official sources (7)
7 clinical guideline checks
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder
Recommendation for the stated population
EMDR is explicitly strongly recommended.
Scope: Adults with PTSD
- Post-traumatic stress disorder (NG116)
Recommendation for the stated population
For adults, NICE considers EMDR at 1–3 months if preferred and offers it after 3 months for non-combat trauma. This scope is not a contraindication for combat trauma.
Scope: Adults after non-combat trauma; separate restricted option for ages 7–17
- Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder in Adults
Recommendation for the stated population
APA conditionally recommends EMDR as a second-line adult PTSD treatment compared with no intervention or treatment as usual.
Scope: Adults with PTSD; comparison with no intervention or treatment as usual
- Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder
Discussed in the source
VA/DoD suggests co-occurring disorders should not preclude these PTSD treatments. This addresses access to treatment, not a separate claim of treating substance use.
Scope: PTSD with co-occurring substance-use disorder or other disorders; therapies named in recommendations 8 and 9.
- Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder in Adults
Insufficient evidence for or against
APA finds insufficient evidence to prefer EMDR over those comparators. Its recommendation versus no treatment or usual care does not establish superiority over active therapy.
Scope: Adults with PTSD; EMDR versus the other active psychological treatments listed in the table.
- Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders
Recommendation for the stated population
WHO includes EMDR in a conditional recommendation. The 2023 guideline book rates certainty as low, while WHO’s web summary reports moderate quality; that discrepancy remains unresolved. Delivery requires appropriate training and supervision.
Scope: Adults with PTSD, within the mhGAP non-specialist-care context.
- Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders
Recommendation for the stated population
WHO includes EMDR in a strong recommendation based on moderate-certainty evidence. Clinicians need relevant training and demonstrated competence; lay providers require comprehensive training and close supervision.
Scope: Children and adolescents with PTSD.
- Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder
- Focus
- Processing
- Format
- Individual
- Duration
- Short-medium
Condition-specific assessments
Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.
PTSD & Acute Trauma
Population and scope: Adults with PTSD receiving individual, manualized EMDR. This does not grade acute post-trauma prevention, pediatric care, attachment-focused EMDR, ketamine-assisted EMDR or other branded adaptations.
Guideline recommendation
VA/DoD 2023 recommendation 8 strongly recommends EMDR for adult PTSD. The American Psychological Association’s 2025 guideline gives a conditional recommendation versus no intervention or usual care. For non-combat-related trauma, NICE NG116 (2018) offers EMDR after more than three months and considers it at one to three months when preferred. WHO STR1 is conditional; its 2023 book reports low certainty while its web summary reports moderate quality, an unresolved discrepancy. These differences remain visible: the label records a guideline recommendation for this adult PTSD protocol, not unanimous recommendation strength, universal first-line status or a claim that EMDR is unsuitable after combat trauma.
Source assessment dated
- VA/DoD (2023): Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder — Recommendation 8; Table 6, printed/PDF p. 36; discussion pp. 46–49
- American Psychological Association (Approved by APA Council of Representatives, February 2025): Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder in Adults — Tier definitions, printed p. 6 / physical PDF p. 10; psychological recommendations, printed p. 7 / physical PDF p. 11; active comparisons, printed p. 9 / physical PDF p. 13; university-hosted copy
- NICE (2018-12-05): Post-traumatic stress disorder (NG116) — EMDR recommendations 1.6.18–1.6.20, printed/physical PDF p. 21
- World Health Organization (Third edition, 20 November 2023): Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders — STR1, printed p. 46 / PDF p. 78; executive summary p. xxii / PDF p. 24
- World Health Organization (2023 update; current HTML read 6 September 2026): Posttraumatic stress disorder (PTSD): psychological interventions – adults — Recommendation, strength and quality-of-evidence fields
Perinatal Mental Health
Population and scope: Adults with PTSD after traumatic birth, miscarriage, stillbirth or neonatal death (NICE CG192 phrases this recommendation for women); standard manual-based EMDR within the non-combat PTSD pathway, rather than treatment of perinatal depression or distress alone.
Guideline recommendation
NICE CG192 offers trauma-focused CBT or EMDR for PTSD resulting from traumatic birth, miscarriage, stillbirth or neonatal death, referring to its PTSD guideline. NICE NG116 distinguishes timing: consider EMDR at one to three months after non-combat trauma when it is preferred, and offer it after three months. It specifies a validated manual and trained, supervised practitioners. This supports EMDR for the stated trauma-related PTSD context, not a general treatment for perinatal depression, grief without PTSD, or prevention in every pregnancy. CG192 separately advises against single-session high-intensity interventions that explicitly relive traumatic birth. These recommendations do not establish safety for every pregnancy or endorse all EMDR adaptations.
Source assessment dated
MDMA-Assisted Therapy
- Tradition
- Psychedelic
- Founder
- MAPS / Mithoefer (2021)
- Review status
- 4 source checks available
- Official sources
Guidelines and official sources (4)
3 clinical guideline checks · 1 regulatory source check
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- NDA 215455: midomafetamine complete response letter
Not a treatment recommendation
The letter verifies the 2024 nonapproval decision and identifies safety reporting, durability and bias concerns. Psychotherapy-contribution questions appear separately as additional comments.
Scope: Midomafetamine application NDA 215455 for PTSD
- Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder
Insufficient evidence for or against
VA/DoD finds insufficient evidence for or against MDMA-assisted psychotherapy. The guideline’s evidence cutoff precedes later trials and regulatory decisions.
Scope: MDMA-assisted psychotherapy for adults with PTSD; evidence reviewed through May 2022.
- Management of Major Depressive Disorder
Recommendation against the stated use
VA/DoD strongly recommends against MDMA for MDD outside research. This 2022 guideline used evidence through January 2021; it does not assess later trials or every diagnosis.
Scope: MDMA for MDD outside research settings.
- Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder in Adults
Insufficient evidence for or against
APA finds insufficient evidence for or against this intervention in the reviewed comparisons.
Scope: Adults with PTSD; MDMA-assisted psychotherapy versus the inactive or low-dose active comparators reviewed.
- NDA 215455: midomafetamine complete response letter
- Focus
- Experiential + Processing
- Format
- Individual (co-therapist)
- Duration
- Short (3 sessions)
How they work
EMDR
Core mechanism: Bilateral stimulation during trauma memory processing facilitates adaptive information processing and memory reconsolidation (proposed)
Ontology: Unprocessed trauma memories stored dysfunctionally with original affect, sensation, and cognition
MDMA-Assisted Therapy
Core mechanism: MDMA reduces the fear response and increases trust and empathy, making it possible to stay with trauma material inside the therapeutic relationship
Ontology: PTSD maintained by overwhelming fear that prevents therapeutic engagement; MDMA lowers this barrier pharmacologically
Related condition topics
These editorial cross-references organize reading. A shared link does not mean both approaches are effective, recommended, or interchangeable for that condition.
2 shared · 6 EMDR-only · 0 MDMA-Assisted Therapy-only
Linked to both entries
Linked only in the EMDR entry
What each assumes — and misses
EMDR
Philosophical roots: Merleau-Ponty (body holds memory); Bion (processing/containment); Pavlov (orienting response); Shapiro (adaptive information processing: pragmatic, not philosophically derived)
Blind spots: Mechanism debate unresolved; protocol fidelity varies; may be applied to conditions beyond its evidence base
Therapeutic voice: Bring up the image and the negative belief. Notice what you feel in your body. Now follow my fingers.
MDMA-Assisted Therapy
Philosophical roots: Mithoefer (inner healing intelligence); Rogers (organismic wisdom, given conditions); Buber (I-Thou enabled pharmacologically); trauma processing theory
Blind spots: FDA declined approval (2024); methodological concerns about unblinding; not currently legally available outside research
Therapeutic voice: You're safe here. If something difficult comes up, you can move toward it. You don't have to do this alone.
Choosing between them
EMDR (Trauma-Focused) and MDMA-Assisted Therapy (Psychedelic) come from different traditions, which means they assume different things about what a person is, what causes suffering, and what the therapeutic relationship is for. The choice between them is often less about "which works better" and more about which set of assumptions fits the client and the therapist.
For deeper coverage: see the full EMDR and MDMA-Assisted Therapy pages, or use the interactive comparison tool to add more modalities to this comparison.